5-year weekly monitoring of community-acquired pneumonia incidence and mortality

Rustem Shaymuratov (Kazan, Republic of Tatarstan, Russian Federation), Rustem Shaymuratov, Alexander Vizel

Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Rustem Shaymuratov (Kazan, Republic of Tatarstan, Russian Federation), Rustem Shaymuratov, Alexander Vizel. 5-year weekly monitoring of community-acquired pneumonia incidence and mortality. Eur Respir J 2016; 48: Suppl. 60, 4247

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The impact of adherence to guidelines for hospitalized community-acquired pneumonia on health outcomes and mortality: A retrospective cohort study
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


In-hospital mortality risk assessment in patients with community acquired pneumonia
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014


Antimicrobial therapy of community-acquired pneumonia (CAP) at an out-patient stage in the Samara region during the 5-year period
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013

Determinants of hospital costs in community-acquired pneumonia
Source: Eur Respir J 2008; 31: 1061-1067
Year: 2008



Risk of hospitalization due to pneumococcal pneumonia in adults in Spain. The CORIENNE study
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


Effect of smoking on prognosis and mortality in patients hospitalized due to community acquired pneumonia
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014

Factors affecting short and long-term mortality after community-acquired pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015

Mortality during hospitalisation for pneumonia in Alberta, Canada, is associated with physician volume
Source: Eur Respir J 2003; 22: 148-155
Year: 2003



Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia
Source: International Congress 2014 – How quality of care impacts cost effectiveness
Year: 2014



Medications associated with the incidence of recurrent pneumonia in Japanese elderly population
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


The impact of comorbidities on the in-hospital mortality in patients with community-acquired pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


Health care-associated pneumonia and community-acquired pneumonia: A single-center experience
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015

Prognostic factors of 30 day mortality in HIV infected patients with community-acquired pneumonia
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014


Incidence of hospitalized all-cause pneumonia, and serotype distribution of hospitalized streptococcus pneumoniae pneumonia in Norway 2008-2009
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013


The neutrophil/lymphocyte ratio in predicting outcome for hospitalized patients with community-acquired pneumonia
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014

Does previous warfarin treatment effect complications and outcome in hospitalised patients with community-acquired pneumonia?
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014


Fatal outcomes in patients with community acquired pneumonia
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013


Performance of early warning score and CURB-65 in predicting severe outcome in community-acquired pneumonia
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016


Quality indicators for management of community-acquired pneumonia
Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders
Year: 2015


Role of procalcitonin in predicting severity and in-hospital mortality in patients with community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016